Entity Addresses, Address Type [Axis]
Business Contact [Member]
Legal Entity [Axis]
Chemomab Therapeutics Ltd [Member]
Related and Nonrelated Parties [Axis]
Related Party [Member]
Equity Components [Axis]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Long-Lived Asset, Class [Axis]
Computer Equipment [Member]
Laboratory Equipment [Member]
Furniture and Fixtures [Member]
Leasehold Improvements [Member]
Award Type [Axis]
United States of America, Dollars
ILS [Member]
Other Currencies [Member]
Computers [Member]
Furniture And Equipment [Member]
Website Development [Member]
Category of Item Purchased [Axis]
New Drug Applicationand Biological License Application [Member]
Capital Additions One [Member]
Sale of Stock [Axis]
Private Placement [Member]
ATM Agreement [Member]
Repurchase Arrangement [Member]
Market Offering Agreement [Member]
Roth Capital Partners Llc [Member]
Lifesci Capital LLC [Member]
Asset Class [Axis]
Accounts Receivable [Member]
Plan Name [Axis]
2015 Plan [Member]
Class of Stock [Axis]
Restricted Ordinary Shares [Member]
2017 Plan [Member]
Research and Development Arrangement [Member]
General and Administrative [Member]
Geographical [Axis]
ISRAEL
Income Tax Jurisdiction [Axis]
Income Tax Jurisdiction, Foreign [Member]
Income Tax Jurisdiction, Domestic Federal [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Investment, Name [Axis]
Combined Company [Member]
Scipher Securityholders [Member]
Chemomab Securityholders [Member]
Pre-funded Warrants [Member]
Restricted Stock Units (RSUs) [Member]
Entity Addresses [Table]
Entity Addresses [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Contact Personnel Name
Statement [Table]
Statement [Line Items]
Assets
Current assets
Cash and cash equivalents
Short term bank deposits
Restricted cash
Other receivables and prepaid expenses
Total current assets
Non-current assets
Long term prepaid expenses
Property and equipment, net
Operating lease right-of-use assets
Total non-current assets
Total assets
Current liabilities
Trade payables
Accrued expenses
Employees and related expenses
Operating lease liabilities
Total current liabilities
Non-current liabilities
Non-current operating lease liabilities
Total non-current liabilities
Commitments and contingent liabilities
Total liabilities
Shareholders’ equity (*)
Ordinary share value
Additional paid in capital
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity
Common stock, no par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Employee and related expenses
Operating expenses
Research and development
General and administrative
Total operating expenses
Financing income, net
Loss before taxes
Taxes on income
Net loss for the period
Basic loss per Ordinary Share
Diluted loss per Ordinary Share
Weighted average number of Ordinary Shares outstanding, basic
Weighted average number of Ordinary Shares outstanding, diluted
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Balance
Balance, shares
Treasury stock, common shares
Share-based compensation
Issuance of shares, net of issuance expenses
Issuance of shares, net of issuance expenses, shares
Sale of treasury shares at cost
Sale of treasury shares at cost, shares
Net loss for the period
Issuance of shares and pre-funded warrants, net of issuance costs
Issuance of shares and pre-funded warrants, net of issuance costs, shares
Exercise of Prefunded warrants
Exercise of Prefunded warrants, shares
Exercise of options
Exercise of options, shares
Exercise of RSA’s
Exercise of RSA's, shares
Balance
Balance, shares
Treasury stock, common shares
Cash flows from operating activities
Adjustments for operating activities:
Depreciation
Capital Loss
Share-based compensation
Change in other receivables and prepaid expenses (short and long term)
Gain on lease termination
Change in trade payables
Change in accrued expenses
Change in employees and related expenses
Change in operating leases
Net cash used in operating activities
Cash flows from investing activities
Decrease in bank deposits
Proceeds from sale of property and equipment
Purchase of fixed assets
Net cash provided by investing activities
Cash flows from financing activities
Exercise of Options
Sale of treasury share
Issuance of shares, net of issuance expenses
Net cash provided by financing activities
Decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplementary cash flows information:
A. Cash paid and received during the year for:
Income taxes received
Interest received
Supplemental disclosure of non-cash investing and financing activities:
Right-of-use asset recognized with corresponding lease liability
Receivables on account of shares issued, net
Issuance costs not paid in cash
Accrued issuance expenses
OrganizationConsolidationAndPresentationOfFinancialStatementsTable [Table]
General
SignificantAccountingPoliciesTable [Table]
Basis of Presentation and Significant Accounting Policies
CashAndCashEquivalentsTable [Table]
Cash and Cash Equivalents
OtherReceivablesAndPrepaidExpensesTable [Table]
Other Receivables and Prepaid Expenses
PropertyAndEquipmentNetTable [Table]
Property and Equipment, Net
LeasesTable [Table]
Leases
CommitmentsAndContingentLiabilitiesTable [Table]
Commitments and Contingent Liabilities
EquityTable [Table]
Share Capital
ResearchAndDevelopmentTable [Table]
Research and Development
GeneralAndAdministrativeTable [Table]
General and Administrative
IncomeTaxesTable [Table]
Income Taxes
RelatedPartiesTable [Table]
Related Parties Balances and Transactions
NetIncomeLossPerShareTable [Table]
Net Loss Per Share Attributable to Ordinary Shareholders
Subsequent Event [Table]
Subsequent events
Segment Reporting [Table]
Segments
Basis of Preparation
Use of estimates
Foreign currency
Cash and cash equivalents
Short-term bank deposits
Restricted cash
Property and equipment
Impairment of long-lived assets
Research and Development
Income taxes
Fair value of financial instruments
Share-based compensation
Government-sponsored research and development
Severance pay
Concentrations of credit risk:
Leases
Segments
Principles of consolidation
Loss per ordinary share
Reclassifications
Newly issued and recently adopted accounting pronouncements
Recently issued accounting standards not yet adopted
Schedule of Annual Rate of Deprecation
Schedule of Components of Cash and Cash Equivalents
Schedule of Other Accounts Receivable and Prepaid Expenses
Schedule of Property and Equipment, Net
Schedule of the Effect of Share-based Compensation on the Statements of Operations
Schedule of Number and Weighted Average Exercise Prices of Option
Schedule of Unvested RSA
Schedule of Assumptions Used to Calculate the Fair Value of the Options
Schedule of Research and Development
Schedule of General and Administrative
Schedule of Deferred Taxes
Schedule of Roll forward of Valuation Allowance
Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense
Schedule of Income (Loss) Before Income Taxes by Jurisdiction
Schedule of Related Party Payables
Schedule of Transactions with Related Parties
Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Ordinary Shareholders
Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders
Losses from operations
Cash flows from operating activities
Cash, cash equivalents, and short-term deposits
AnnualRateOfDeprecationTable [Table]
Annual rates of depreciation
Annual rates of depreciation
Percentage of short term deposits
Impairment of long lived assets
Percentage of monthly deposits rate
Severance costs
Incremental borrowing rate
Number of reportable segment
Government institutions
Prepaid expenses
Receivable from sale of ADSs
Other receivables and prepaid expenses
Cost
Less - accumulated depreciation
Property and equipment, net
Depreciation expense
Lease term, option to extend
Management fees
Bank guarantees to property owner
Operating right-of-use assets and operating lease liabilities
Operating lease liabilities
Incremental borrowing rate based on credit rating
Lease term
Long-Term Purchase Commitment [Table]
Long-Term Purchase Commitment [Line Items]
Description of application payment for licensed product
Licensed product payment
Decsription of occurrence for payments
Royalty payments on sale of product
Maximum percentage of payments of royalties
Cumulative amounts of grants received
Royality expenses
Advances to subcontractor
Bank restricted deposit
Accretion expense
Accrued income taxes
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-based compensation expenses
Weighted average exercise price, Outstanding at the beginning
Number of options, Outstanding at the beginning
Weighted average remaining contractual life, Outstanding
Weighted average exercise price, Exercise
Number of options, Exercised
Weighted average exercise price, Forfeited
Number of options, Forfeited
Weighted average exercise price, Granted
Number of options, Granted
Weighted average remaining contractual life, Granted
Weighted average exercise price, Outstanding at ending
Number of options, Outstanding at the ending
Unvested at beginning of the year
Granted
Issuance of ordinary shares upon vesting of RSAs
Forfeited
Outstanding at June 30, 2026
Weighted average share price
Exercise price
Expected life of options
Expected volatility, minimum
Expected volatility, maximum
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Dividend yield
Description of american depositary shares ratio
Number of warrants purchase ADS's
Number of ADSs issued
Share price per share
Proceeds from sale of ADS's
Aggregate offering price of at the market offering agreement
Number of shares repurchase of ADSs
Repurchase of ADSs
Weighted average price of repurchase of ADSs
Total consideration of repurchase of ADSs
Proceeds from sale of treasury stock
Consideration of repurchase of ADS
Number of stock reserved for issuance
Number of stock adss resvered for issuance
Number of shares issued
Number of options issuable outstanding
Number of ADSs options issuable outstanding
Number of options vested and exercisable
Number of ADSs vested and exercisable
Weighted average exercise price
Weighted average exercise price of ADSs
Options to purchase ADS cancelled
Options to purchase ordinary shares cancelled
Number of shares converted into ordinary shares
Number of shares converted into ordinary shares, American Depositary Shares
Consultants and subcontractors
Salaries and related expenses
Lease and maintenance
Share-based compensation
Other expenses
Total
Salaries, fees and related expenses
Professional services
Share-based compensation
Fees to directors
Directors’ and Officers’ Insurance
Lease and maintenance
Other expenses
General and administrative
DeferredTaxesTable [Table]
Net operating loss carryforward
Capital losses
Share-based compensation expense
Capitalized research and development costs
Other
Deferred tax assets
Less - valuation allowance
Net deferred tax assets, net of valuation allowance
Tax credit carryforward valuation allowance
Amount of benefit of deferred tax assets offset by a valuation allowance
ScheduleOfRollForwardOfValuationAllowanceTable [Table]
Valuation allowance, balance
Currency translation Income
Increase in valuation allowance
Increase in valuation allowance for capital losses
Decrease in valuation allowance
Net increase during the year
Valuation allowance, balance
Loss before income taxes
Israeli statutory income tax rate, percentage
Share-based compensation
Share-based compensation, percentage
Other
Nontaxable income or nondeductible expenses:, percentage
Change in valuation allowance
Change in valuation allowance, percentage
Other
Other, percentage
Foreign tax effects
Foreign tax effects, percentage
Actual income tax expense (Benefit)
Actual income tax expenses, percentage
Theoretical tax benefit
Change in temporary differences for which deferred taxes were not recognized
Tax rate differential
Non-deductible expenses
Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards
IncomeLossBeforeIncomeTaxesTable [Table]
Israel
Foreign
Total
Statutory tax rate
Operating loss carryforwards
Unrecognized tax benefits
Total
Salaries and related expenses
Share-based compensation
Professional Services
Research and development
Total
BasicAndDilutedNetLossPerShareTable [Table]
Net loss
Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders - basic
Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders - diluted
Net loss per share attributable to ordinary shareholders, basic
Net loss per share attributable to ordinary shareholders, diluted
Outstanding options to purchase ordinary shares and RSAs
Number of reportable segments
Subsequent Event [Line Items]
Gross proceeds
Ownership percentage
Capital loss.
Income taxes received.
Interest received.
Receivables on account of shares issued net.
Short Term Bank Deposits [Policy Text Block]
Percentage of short term deposits.
Tax credit carryforward valuation allowance amount.
Aggregate offering price of at market offering agreement.
ATM Agreement [Member]
Benefit of deferred tax assets Off set by valuation allowance.
Repurchase of american depositary receipts shares.
Repurchase Arrangement [Member]
Repurchase of american eepositary receipts.
Weighted Average Price Of Repurchase Of American Depositary Receipts.
Consideration of repurchase of american depositary receipts.
Market Offering Agreement [Member]
Roth Capital Partners Llc [Member]
Lifesci Capital LLC [Member]
Number of stock reserved for issuance.
2015 Plan [Member]
Number of stock adss resvered for issuance.
Receivables on account of shares issued net.
Number Of Options issuable outstanding.
Number of options vested and exercisable.
Number of adds vested and exercisable.
Share based compensation arrangement by share based payment.
Share based compensation arrangement by share based payment.
Consideration of repurchase.
Restricted Ordinary Shares [Member]
Number of shares converted into ordinary share.
Number of shares converted into ordinary.
2017 Plan [Member]
Schedule Of Annual Rate Of Deprecation [Table Text Block]
Laboratory Equipment [Member]
Government Assistance Accounting [Policy Text Block]
Severance Pay [Policy Text Block]
Defined contribution plan maximum employer contribution percent.
Lessee operating lease incremental borrowing rate.
Recently Issued Accounting Standards Not Yet Adopted [Policy Text Block]
ILS [Member]
Other Currencies [Member]
Government receivable current.
Schedule Of Other Accounts Receivable And Prepaid Expenses [Table Text Block]
Computers [Member]
Furniture And Equipment [Member]
Website Development [Member]
Operating rright of use assets.
New Drug Applicationand Biological License Application [Member]
Licensed product payment.
Capital Additions One [Member]
Description of american depositary shares ratio.
Number of warrants purchase up adss.
Stock issued during period american.
Percentage of royalty payments.
Sale of stocks price per share.
Maximum percentage of payments of royalties.
Cumulative amounts of grants.
Proceeds from sale of asdss.
Bank restricted deposit.
Stock issued during period shares option.
Stock issued during period shares option.
General and Administrative [Member]
Schedule of Research and Development [Table Text Block]
Consultants and subcontractors expense.
Rent and maintenance research and development expense.
Share based compensation research and development expense .
General and Administrative Disclosure [Text Block]
Share based compensation general and administrative expense.
Rent and maintenance general and administrative expense.
Schedule of General and Administrative [Table Text Block]
Currency transaction loss valuation allowance.
Increase in valuation allowance for capital losses amount.
Valuation allowance deferred tax asset decrease amount.
Valuation allowance deferred tax asset net increase amount.
Income tax reconciliation non deductible expense other foreign jurisdictions.
Income tax reconciliation non deductible expense other foreign jurisdictions percent.
Change in temporary differences for deferred tax not recognized.
Losses and benefits for tax purposes for year for which deferred taxes were not recorded.
Schedule of Related Party Payables [Table Text Block]
Related party transaction salaries and related expenses from transactions with related party.
Related party transaction share based payments from transactions with related party.
Related party transaction professional services from transactions with related party.
Related party transaction research and development expense from transactions with related party.
Stock issued during period value shares and prefunded warrants issuance costs.
Stock issued during period shares shares and prefunded warrants issuance costs.
Stock issued during period value exercise of prefunded warrants.
Stock issued during period shares exercise of prefunded warrants.
Annual rates of depreciation.
Bank guarantees to property owner.
Advances to subcontractor.
Number of options issuable outstanding.
Chemomab Therapeutics Ltd [Member]
Total [Member]
Stock issued during period shares restricted stock awards exercised.
Stock issued during period value restricted stock awards exercised.
Accrued issuance expenses.
Combined Company [Member]
Scipher Securityholders [Member]
Chemomab Securityholders [Member]
Decrease in short term bank deposits.
Pre-funded Warrants [Member]
Assets, Current
Assets, Noncurrent
Assets [Default Label]
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Income Tax Expense (Benefit)
Shares, Outstanding
Treasury Stock, Common, Shares
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Prepaid Expense and Other Assets
Gain (Loss) on Termination of Lease
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Proceeds from Other Equity
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Research and Development Expense, Policy [Policy Text Block]
Share-Based Payment Arrangement [Policy Text Block]
Lessee, Leases [Policy Text Block]
Segment Reporting, Policy [Policy Text Block]
Operating Income (Loss)
AnnualRatesOfDepreciation
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Operating Lease, Liability
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
StockIssuedDuringPeriodSharesStockOptionsExercised1
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
ShareBasedCompensationResearchAndDevelopmentExpense
ShareBasedCompensationGeneralAndAdministrativeExpense
RentAndMaintenanceGeneralAndAdministrativeExpense
Other General and Administrative Expense
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
CurrencyTransactionLossValuationAllowance
ValuationAllowanceDeferredTaxAssetDecreaseAmount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
Effective Income Tax Rate Reconciliation, Percent
RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty
RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty
RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty
Cost of Revenue